NCT07659795
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07659795
Title A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer (TARGET-D 203)
Acronym TARGET-D 203
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
Valkyrie Clinical Trials (contact for more locations) RECRUITING Los Angeles California 90067 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Indiana University, Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
START New Jersey RECRUITING East Brunswick New Jersey 08816 United States Details
START Dallas Fort Worth RECRUITING Fort Worth Texas 76104 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
UVA Comprehensive Cancer Center RECRUITING Charlottesville Virginia 22908 United States Details
Virginia Mason Medical Center RECRUITING Seattle Washington 98101 United States Details
Icon Cancer Centre South Brisbane RECRUITING South Brisbane Queensland 4101 Australia Details
Icon Cancer Centre Adelaide RECRUITING Kurralta Park South Australia 5037 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field